miR-1294在胃癌中表达的临床意义及其对胃癌细胞增殖、侵袭和迁移的影响
Clinical Significance of miR-1294 Expression in Gastric Cancer and Its Effect on Proliferation, Invasion and Migration of Gastric Cancer Cells
DOI: 10.12677/ACM.2020.1012459, PDF,    科研立项经费支持
作者: 蔡惠美, 林 晖*, 曹文瑜, 孙 娟:福建医科大学附属福州市第一医院消化内科,福建 福州;欧希龙:东南大学附属中大医院消化科,江苏 南京;黄钰钿:福建医科大学附属福州市第一医院病理科,福建 福州;方跃华:福建医科大学附属福州市第一医院检验科,福建 福州
关键词: miR-1294预后增殖侵袭迁移胃癌miR-1294 Prognosis Proliferation Invasion Migration Gastric Cancer
摘要: 目的:探讨miR-1294在胃癌中表达的预后价值,及其对胃癌细胞增殖、侵袭和迁移的影响。方法:通过实时荧光定量PCR (qRT-PCR)检测miR-1294在胃癌组织及癌旁正常组织中的表达情况,分析其与患者临床病理特征的关系,并利用Kaplan-Meier生存曲线和Cox回归分析对其在胃癌中的预后价值进行评估。在胃癌细胞中,通过MTT和Transwell实验检测miR-1294表达量对癌细胞生命活动的影响。结果:胃癌组织中miR-1294的表达水平显著低于癌旁正常组织(P < 0.05),且与肿瘤组织分化程度、淋巴结转移及TNM分期均显著相关(P < 0.05)。miR-1294低表达患者的总体生存率较差(log-rank P < 0.01)。多因素Cox分析表明,miR-1294是胃癌的独立预后因子。MTT和Transwell检测显示,胃癌细胞增殖、侵袭和迁移能力在miR-1294干扰组中较对照组显著增加(P < 0.01)。结论:低表达miR-1294促进胃癌细胞的增殖、侵袭和迁移,与胃癌的不良预后相关。
Abstract: Aims: To explore the prognostic value of miR-1294 expression in gastric cancer patients and investigate the effect of miR-1294 on cancer cell proliferation, invasion and migration. Method: The expression of miR-1294 was detected by quantitative real-time PCR (qRT-PCR), and the relevance of miR-1294 to the clinicopathological feature was further analyzed. The prognostic value of miR-1294 was evaluated using Kaplan-Meier survival analysis and Cox regression assay. Effects of miR-1294 expression on cell biological behaviors of gastric cancer cells were analyzed using MTT and Transwell analysis. Results: The miR-1294 expression in gastric cancer tissues was significantly lower than that in the adjacent normal ones (P < 0.05), which was significantly related to the tumor differentiation, lymph node metastases and TNM stage (P < 0.05). The gastric cancer patients with lower miR-1294 expression had poor overall survival compared with those with higher miR-1294 expression (log-rank P < 0.01). According to the Cox analysis, the miR-1294 expression was identified as an independent prognostic factor for gastric cancer. MTT and Transwell assay showed that the cell proliferation, invasion and migration in the miR-1294 interference group were significantly promoted compared with corresponding controls (P < 0.01). Conclusion: Down regulated miR-1294 expression promotes the proliferation, invasion and migration of gastric cancer cells, which is associated with poor prognosis of gastric cancer.
文章引用:蔡惠美, 林晖, 曹文瑜, 欧希龙, 孙娟, 黄钰钿, 方跃华. miR-1294在胃癌中表达的临床意义及其对胃癌细胞增殖、侵袭和迁移的影响[J]. 临床医学进展, 2020, 10(12): 3060-3068. https://doi.org/10.12677/ACM.2020.1012459

参考文献

[1] 弓艳霞, 唐艳萍, 郭丽, 等. 地区差异对胃癌疾病特征的影响[J]. 世界华人消化杂志, 2016, 24(7): 1092-1097.
[2] Ferro, A., Peleteiro, B., Malvezzi, M., et al. (2014) Worldwide Trends in Gastric Cancer Mortality (1980-2011), with Predictions to 2015, and Incidence by Subtype. European Journal of Cancer, 50, 1330-1344. http://www.ncbi.nlm.nih.gov/pubmed/24650579 [Google Scholar] [CrossRef] [PubMed]
[3] Zhang, X., Yuan, Y., Xi, Y., et al. (2018) Cinobufacini Injection Improves the Efficacy of Chemotherapy on Advanced Stage Gastric Cancer: A Systemic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine, 2018, Article ID: 7362340. https://www.ncbi.nlm.nih.gov/pubmed/30254688 [Google Scholar] [CrossRef] [PubMed]
[4] Kaplan, M.A., Kucukoner, M., Inal, A., et al. (2014) Relationship between Serum Soluble Vascular Adhesion Protein-1 Level and Gastric Cancer Prognosis. Oncology Research and Treatment, 37, 340-344. http://www.ncbi.nlm.nih.gov/pubmed/24903765 [Google Scholar] [CrossRef] [PubMed]
[5] Mu, G.C., Huang, Y., Liu, Z.M., et al. (2019) Relationship between Celiac Artery Variation and Number of Lymph Nodes Dissection in Gastric Cancer Surgery. World Journal of Gastrointestinal Oncology, 11, 499-508. https://www.ncbi.nlm.nih.gov/pubmed/31236200 [Google Scholar] [CrossRef] [PubMed]
[6] Ha, M. and Kim, V.N. (2014) Regulation of microRNA Biogenesis. Nature Reviews Molecular Cell Biology, 15, 509-524. http://www.ncbi.nlm.nih.gov/pubmed/25027649 [Google Scholar] [CrossRef] [PubMed]
[7] Zhang, X., Shen, B. and Cui, Y. (2019) Ago HITS-CLIP Expands microRNA-mRNA Interactions in Nucleus and Cytoplasm of Gastric Cancer Cells. BMC Cancer, 19, 29. https://www.ncbi.nlm.nih.gov/pubmed/30621629 [Google Scholar] [CrossRef] [PubMed]
[8] 王兰, 袁芳芳, 吕晓慧, 等. miRNA与肿瘤性疾病相关研究进展[J]. 畜牧与饲料科学, 2014, 35(9): 33-38.
[9] Rupaimoole, R. and Slack, F.J. (2017) MicroRNA Therapeutics: Towards a New Era for the Management of Cancer and Other Diseases. Nature Reviews Drug Discovery, 16, 203-222. http://www.ncbi.nlm.nih.gov/pubmed/28209991 [Google Scholar] [CrossRef] [PubMed]
[10] Liu, K., Li, L., Rusidanmu, A., et al. (2015) Down-Regulation of MiR-1294 Is Related to Dismal Prognosis of Patients with Esophageal Squamous Cell Carcinoma through Elevating C-MYC Expression. Cellular Physiology and Biochemistry, 36, 100-110. http://www.ncbi.nlm.nih.gov/pubmed/25925090 [Google Scholar] [CrossRef] [PubMed]
[11] Zhang, Y., Huang, S., Guo, Y., et al. (2018) MiR-1294 Confers Cisplatin Resistance in Ovarian Cancer Cells by Targeting IGF1R. Biomedicine & Pharmacotherapy, 106, 1357-1363. http://www.ncbi.nlm.nih.gov/pubmed/30119207 [Google Scholar] [CrossRef] [PubMed]
[12] Chen, H., Liu, L., Li, X., et al. (2018) MicroRNA-1294 Inhibits the Proliferation and Enhances the Chemosensitivity of Glioma to Temozolomide via the Direct Targeting of TPX2. American Journal of Cancer Research, 8, 291-301. http://www.ncbi.nlm.nih.gov/pubmed/29511599
[13] Shi, Y.X., Ye, B.L., Hu, B.R., et al. (2018) Expression of miR-1294 Is Downregulated and Predicts a Poor Prognosis in Gastric Cancer. European Review for Medical and Pharmacological Sciences, 22, 5525-5530. http://www.ncbi.nlm.nih.gov/pubmed/30229824
[14] Japanese Gastric Cancer Association (2017) Japanese Gastric Cancer Treatment Guidelines 2014 (ver. 4). Gastric Cancer, 20, 1-19. http://www.ncbi.nlm.nih.gov/pubmed/27342689 [Google Scholar] [CrossRef] [PubMed]
[15] Gouaze-Andersson, V., Gherardi, M.J., Lemarie, A., et al. (2018) FGFR1/FOXM1 Pathway: A Key Regulator of Glioblastoma Stem Cells Radioresistance and a Prognosis Biomarker. Oncotarget, 9, 31637-31649. http://www.ncbi.nlm.nih.gov/pubmed/30167084 [Google Scholar] [CrossRef] [PubMed]
[16] Yan, W., Yu, H., Li, W., et al. (2018) Plk1 Promotes the Migration of Human Lung Adenocarcinoma Epithelial Cells via STAT3 Signaling. Oncology Letters, 16, 6801-6807. http://www.ncbi.nlm.nih.gov/pubmed/30405824 [Google Scholar] [CrossRef] [PubMed]
[17] Zhou, M., Chen, X., Wu, J., et al. (2018) MicroRNA-143 Regulates Cell Migration and Invasion by Targeting GOLM1 in Cervical Cancer. Oncology Letters, 16, 6393-6400. http://www.ncbi.nlm.nih.gov/pubmed/30405775 [Google Scholar] [CrossRef] [PubMed]
[18] Nikolouzakis, T.K., Vassilopoulou, L., Fragkiadaki, P., et al. (2018) Improving Diagnosis, Prognosis and Prediction by Using Biomarkers in CRC Patients (Review). Oncology Reports, 39, 2455-2472. http://www.ncbi.nlm.nih.gov/pubmed/29565457 [Google Scholar] [CrossRef] [PubMed]
[19] Wang, Y., Li, J., Dai, L., et al. (2018) MiR-17-5p May Serve as a Novel Predictor for Breast Cancer Recurrence. Cancer Biomarkers: Section A of Disease Markers, 22, 721-726. http://www.ncbi.nlm.nih.gov/pubmed/29914008 [Google Scholar] [CrossRef
[20] Hu, M.L., Xiong, S.W., Zhu, S.X., et al. (2018) MicroRNAs in Gastric Cancer: From Bench to Bedside. Neoplasma, 66, 176-186. http://www.ncbi.nlm.nih.gov/pubmed/30509106
[21] Noorolyai, S., Mokhtarzadeh, A., Baghbani, E., et al. (2018) The Role of microRNAs Involved in PI3-Kinase Signaling Pathway in Colorectal Cancer. Journal of Cellular Physiology, 234, 5664-5673. http://www.ncbi.nlm.nih.gov/pubmed/30488557 [Google Scholar] [CrossRef] [PubMed]
[22] Braga, E.A., Loginov, V.I., Filippova, E.A., et al. (2018) Diagnostic Value of a Group of MicroRNA Genes Hypermethylated in Ovarian Carcinoma. Bulletin of Experimental Biology and Medicine, 166, 253-256. http://www.ncbi.nlm.nih.gov/pubmed/30488208 [Google Scholar] [CrossRef] [PubMed]
[23] Wang, Z., Yan, J., Zou, T., et al. (2018) MicroRNA-1294 Inhibited Oral Squamous Cell Carcinoma Growth by Targeting c-Myc. Oncology Letters, 16, 2243-2250. http://www.ncbi.nlm.nih.gov/pubmed/30008925 [Google Scholar] [CrossRef] [PubMed]